Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilars in supportive care.
Foreman E. Foreman E. Curr Opin Oncol. 2020 Jul;32(4):282-288. doi: 10.1097/CCO.0000000000000631. Curr Opin Oncol. 2020. PMID: 32541314 Review.
International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care.
Frazer MB, Bubalo J, Patel H, Siderov J, Cubilla M, De Lemos M, Dhillon H, Harchowal J, Kuchonthara N, Livinalli A, Macedo R, Mwangi W, Nomura H, O'Connor S, Patterson M, Seadi Torriani M, Yim B, Chan A, Foreman E. Frazer MB, et al. Among authors: foreman e. J Oncol Pharm Pract. 2020 Apr;26(3_suppl):3-10. doi: 10.1177/1078155219893441. J Oncol Pharm Pract. 2020. PMID: 32268831
Preface.
Foreman E, Chan A. Foreman E, et al. J Oncol Pharm Pract. 2020 Apr;26(3_suppl):2. doi: 10.1177/1078155220917184. J Oncol Pharm Pract. 2020. PMID: 32268829 No abstract available.
Multiple cardiotoxicities during osimertinib therapy.
Kobat H, Davidson M, Elkonaissi I, Foreman E, Nabhani-Gebara S. Kobat H, et al. Among authors: foreman e. J Oncol Pharm Pract. 2023 Mar 21:10781552231164301. doi: 10.1177/10781552231164301. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 36942434 Free article.
55 results